Literature DB >> 18956684

[Study on the correlation between CETP TaqIB, KCNE1 S38G and eNOS T-786C gene polymorphisms for predisposition and non-valvular atrial fibrillation].

Li-Xin Xu1, Wei-Yu Yang, Huai-Qin Zhang, Zhi-Hua Tao, Cheng-Cheng Duan.   

Abstract

OBJECTIVE: To study whether CETP TaqIB,KCNE1 S38G and eNOS T-786C genetic polymorphisms are associated with non-valvular atrial fibrillation in the Han population from Zhejiang province.
METHODS: Polymerase chain reaction restriction fragment length polymorphism assay was used to detect the distribution of alleles and genotypes of CETP TaqIB, KCNE1 S38G and eNOS T-786C in 147 patients with non-valvular atrial fibrillation and in 147 subjects as controls in Han population of Zhejiang province.
RESULTS: (1) The frequency of CETP B1 allele in NVAF patients was higher than that of the control group and showing a statistically significant difference (OR = 1.763, 95% CI: 1.247-2.492, P = 0.002). (2) Results from logistic regression analysis revealed that: after adjustment of confounding variables such as sex, age, smoking, hypertension and body mass index, data from the binary logistic analysis showed a statistically significant difference in CETP TaqIB genetic polymorphism between patients and controls. (3) From multifactor dimensionality reduction analysis, results showed an interaction of CETP TaqIB, KCNE1 S38G and eNOS T-786C genetic polymorphisms. Odds ratio of the three simultaneously existing genetic polymorphisms was 1.849 times more than CETP TaqIB alone.
CONCLUSION: CETP BI allele was an independent risk factor for predisposition to non-valvular atrial fibrillation. These findings suggested that the simultaneous existence of CETP B1, KCNE1 S38G and eNOS T-786C allele might be elevated with the predisposition to non-valvular atrial fibrillation in the Han population of Zhejiang province.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956684

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  8 in total

Review 1.  Association between endothelial nitric oxide synthase polymorphisms and atrial fibrillation: a meta-analysis.

Authors:  Hongying Chen; Hongxia Chu; Yu Shi; Soumitra Sudip Bhuyan; Jian ping Li; Shao Rong Liu; Jun Yang
Journal:  J Cardiovasc Transl Res       Date:  2012-06-22       Impact factor: 4.132

2.  Association of KCNE1 genetic polymorphisms with atrial fibrillation in a Chinese Han population.

Authors:  Juan Yao; Yi-Tong Ma; Xiang Xie; Fen Liu; Bang-Dang Chen
Journal:  Genet Test Mol Biomarkers       Date:  2012-09-28

Review 3.  KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation.

Authors:  Geoffrey W Abbott
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

4.  Prediction of gene-phenotype associations in humans, mice, and plants using phenologs.

Authors:  John O Woods; Ulf Martin Singh-Blom; Jon M Laurent; Kriston L McGary; Edward M Marcotte
Journal:  BMC Bioinformatics       Date:  2013-06-21       Impact factor: 3.169

Review 5.  Association between KCNE1 G38S gene polymorphism and risk of atrial fibrillation: A PRISMA-compliant meta-analysis.

Authors:  Yu-Feng Jiang; Min Chen; Nan-Nan Zhang; Hua-Jia Yang; Lang-Biao Xu; Qing Rui; Si-Jia Sun; Jia-Lu Yao; Ya-Feng Zhou
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  KCNE1 rs1805127 polymorphism increases the risk of atrial fibrillation: a meta-analysis of 10 studies.

Authors:  Chang Liang; Xiankai Li; Yawei Xu; Qingyong Chen; Yadong Wu; Wan Wang; Weiming Li; Mantang Qiu
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

Review 7.  Arrhythmogenic KCNE gene variants: current knowledge and future challenges.

Authors:  Shawn M Crump; Geoffrey W Abbott
Journal:  Front Genet       Date:  2014-01-24       Impact factor: 4.599

Review 8.  Mink S38G gene polymorphism and atrial fibrillation in the Chinese population: a meta-analysis of 1871 participants.

Authors:  Yan-yan Li; Lian-sheng Wang; Xin-zheng Lu
Journal:  ScientificWorldJournal       Date:  2014-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.